The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: omalizumab     Quarter: 2016Q3

Total Drug/Injury Combinations: 175     Number of Pages: 9

DRUGNAME PT EventCount
Omalizumab Dysphonia 4 view events
Omalizumab Fibromyalgia 4 view events
Omalizumab Heart rate increased 4 view events
Omalizumab Hypersensitivity 4 view events
Omalizumab Hypotension 4 view events
Omalizumab Lower respiratory tract infection 4 view events
Omalizumab Myalgia 4 view events
Omalizumab Peripheral swelling 4 view events
Omalizumab Pulse volume decreased 4 view events
Omalizumab Sinus congestion 4 view events
Omalizumab Sleep apnoea syndrome 4 view events
Omalizumab Suffocation feeling 4 view events
Omalizumab Throat irritation 4 view events
Omalizumab Tooth abscess 4 view events
Omalizumab Wheezing 4 view events
Omalizumab Wound 4 view events
Omalizumab Bronchiolitis 3 view events
Omalizumab Ear infection 3 view events
Omalizumab Foetal exposure during pregnancy 3 view events
Omalizumab Lip swelling 3 view events

Total Drug/Injury Combinations: 175     Number of Pages: 9

NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)